PROGENTOS THERAPEUTICS
Live / Applied — Second extension granted (statement of use) (as of 22 Jan 2026)
What this means for you
Not registered yet, but its 14 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98404794
- Mark type
- Stylized text
- Filed
- 14 Feb 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used to treat diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders
- Class 042 — Scientific and technological services: Medical and scientific research and development in the field of diseases of the central nervous system, neurological diseases, autoimmune disorders, diseases of the central and peripheral nervous system, and musculoskeletal disorders
Owner
- Progentos Therapeutics, Inc., Watertown, MA, US
- Progentos Therapeutics, Inc., Watertown, MA, US
Prosecution history
- 23 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2026 — SOU EXTENSION 2 GRANTED
- 22 Jan 2026 — SOU EXTENSION 2 FILED
- 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 1 GRANTED
- 12 Aug 2025 — SOU EXTENSION 1 FILED
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2024 — EXAMINER'S AMENDMENT ENTERED
- 22 Oct 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED